ARCHIVE

• Gov't Allows Private Companies to Operate Medical Institutions
  March 10, 2003

• RESEARCH & DEVELOPMENT NEWS IN BRIEF
  March 10, 2003

• Schedule for Changes in Approval Procedures Outlined
  March 10, 2003

• Toyama Transfers OTC Products to Taisho, Kyorin
  March 10, 2003

• PFSB Taking Public Comments on Amended PAL Ordinances
  March 10, 2003

• JACDS Drafting GLs for Introduction of Category Management
  March 10, 2003

• JMA to Stress Need for Higher Price Adjustment Zone
  March 10, 2003

• OTC NEWS IN BRIEF
  March 10, 2003

• Package Insert Revisions for Edaravone Required: Safety Info
  March 10, 2003

• DIAGNOSTIC NEWS IN BRIEF
  March 10, 2003

• No Conclusion Reached on Drug Patent Issue at TRIPS Board Meeting
  March 10, 2003

• Draft Ministerial Ordinances, Notifications on Amended PAL Approved: Medical Device Panel
  March 10, 2003

• Ethical Drug Market Likely to Grow At Least 4% in FY2002
  March 10, 2003

• GL for INF Treatment of Chronic Hepatitis C Prepared by Korosho Study Group
  March 10, 2003

• MEDICAL DEVICE NEWS IN BRIEF
  March 10, 2003

• BULLETIN
  March 10, 2003

• REGULATORY NEWS IN BRIEF
  March 10, 2003

• Eisai's Overseas Sales to Rise to 53% of Total in FY2006: President Naito
  March 10, 2003

• Novartis Refocusing Marketing Efforts on Zaditen
  March 10, 2003

• WORLD NEWS IN BRIEF
  March 10, 2003

ページ

• « 先頭
• ‹ Prev
• …
• 613
• 614
• 615
• 616
• 617
• 618
• 619
• 620
• 621
• …
• Next ›
• 最終 »